Marino, Stram & Associates LLC Magenta Therapeutics, Inc. Transaction History

Marino, Stram & Associates LLC

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Jul 19, 2019	SELL	$13.4 - $17.67 $21,842 - $28,802	-1,630 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$11.32 - $15.7 $18,451 - $25,591	1,630 New	1,630 $20,000
Q2 2018 Aug 14, 2018	BUY	$13.5 - $14.52 $0 - $0	0 New	0 $22,000

442K

Ticker MGTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,890,500
Description
Magenta Therapeutics, Inc., a clinical-stage biotechnology company, develops medicines to bring the curative power of stem cell transplants to patients with blood cancers, genetic diseases, and autoimmune diseases. It develops MGTA-117, an anti-CD117 antibody that targets hematopoietic stem cells (HSCs) and genetically mutated stem cells that ca...

Get notified when there are updates to the investment portfolio of Marino, Stram & Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Marino, Stram & Associates LLC with notifications on news.